Search research articles
Contact Us
Filters
Showing results (261-270 of 287) with videos related to
Page
of 29
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
September 24, 2010
Microarray and allergenic activity assessment of milk allergens
H Hochwallner, U Schulmeister, I Swoboda, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 18, 2004
Vaccination with genetically engineered allergens prevents progression of allergic disease
V Niederberger, F Horak, S Vrtala, et al.
Allergy
|
October 31, 2017
Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study
J Eckl-Dorna, R Fröschl, C Lupinek, et al.
Allergy
|
July 26, 2016
Infant milk formulas differ regarding their allergenic activity and induction of T-cell and cytokine responses
H Hochwallner, U Schulmeister, I Swoboda, et al.
Allergy
|
May 4, 2026
Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge
N J Campion, S Villazala-Merino, C Morgenstern, et al.
Allergy
|
May 1, 2008
Characterization of Der p 21, a new important allergen derived from the gut of house dust mites
M Weghofer, Y Dall'Antonia, M Grote, et al.
Allergy
|
May 18, 2011
Patients suffering from non-IgE-mediated cow's milk protein intolerance cannot be diagnosed based on IgG subclass or IgA responses to milk allergens
H Hochwallner, U Schulmeister, I Swoboda, et al.
Allergy
|
February 3, 2017
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper
M H Shamji, J H Kappen, M Akdis, et al.
Allergy
|
January 20, 2018
Molecular allergen profiling in horses by microarray reveals Fag e 2 from buckwheat as a frequent sensitizer
L Einhorn, G Hofstetter, S Brandt, et al.
Allergy
|
March 3, 2025
Phase 2-3 Trial: Prevention of the Progression to Moderate and Severe COVID-19 in SARS-CoV-2-Infected Non-Hospitalized Adults With Inhaled siRNA-Based MIR 19
M Khaitov, A Nikonova, V Smirnov, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 287) with videos related to
Sort By:
Page
of 29
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
September 24, 2010
Microarray and allergenic activity assessment of milk allergens
H Hochwallner, U Schulmeister, I Swoboda, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 18, 2004
Vaccination with genetically engineered allergens prevents progression of allergic disease
V Niederberger, F Horak, S Vrtala, et al.
Allergy
|
October 31, 2017
Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study
J Eckl-Dorna, R Fröschl, C Lupinek, et al.
Allergy
|
July 26, 2016
Infant milk formulas differ regarding their allergenic activity and induction of T-cell and cytokine responses
H Hochwallner, U Schulmeister, I Swoboda, et al.
Allergy
|
May 4, 2026
Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge
N J Campion, S Villazala-Merino, C Morgenstern, et al.
Allergy
|
May 1, 2008
Characterization of Der p 21, a new important allergen derived from the gut of house dust mites
M Weghofer, Y Dall'Antonia, M Grote, et al.
Allergy
|
May 18, 2011
Patients suffering from non-IgE-mediated cow's milk protein intolerance cannot be diagnosed based on IgG subclass or IgA responses to milk allergens
H Hochwallner, U Schulmeister, I Swoboda, et al.
Allergy
|
February 3, 2017
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper
M H Shamji, J H Kappen, M Akdis, et al.
Allergy
|
January 20, 2018
Molecular allergen profiling in horses by microarray reveals Fag e 2 from buckwheat as a frequent sensitizer
L Einhorn, G Hofstetter, S Brandt, et al.
Allergy
|
March 3, 2025
Phase 2-3 Trial: Prevention of the Progression to Moderate and Severe COVID-19 in SARS-CoV-2-Infected Non-Hospitalized Adults With Inhaled siRNA-Based MIR 19
M Khaitov, A Nikonova, V Smirnov, et al.
Page
of 29